vs
KESTRA MEDICAL TECHNOLOGIES, LTD.（KMTS）与PRO DEX INC（PDEX）财务数据对比。点击上方公司名可切换其他公司
KESTRA MEDICAL TECHNOLOGIES, LTD.的季度营收约是PRO DEX INC的1.2倍（$22.6M vs $18.7M），PRO DEX INC净利率更高（11.7% vs -145.3%，领先157.0%），PRO DEX INC自由现金流更多（$3.5M vs $-25.6M）
Kestra Medical Technologies（KMTS）是一家专注于微创医疗器械研发、生产与商业化的医疗科技企业，核心产品覆盖介入心脏病学与结构性心脏病治疗领域，市场覆盖北美、欧洲及亚太重点区域，服务全球医疗机构与患者。
Pro Dex Inc是一家精密制造企业，主要为医疗设备原始设备制造商以及航空航天、工业领域客户生产定制机加工部件、组件和成品，核心运营市场覆盖北美地区。
KMTS vs PDEX — 直观对比
营收规模更大
KMTS
是对方的1.2倍
$18.7M
净利率更高
PDEX
高出157.0%
-145.3%
自由现金流更多
PDEX
多$29.1M
$-25.6M
损益表 — Q2 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $22.6M | $18.7M |
| 净利润 | $-32.8M | $2.2M |
| 毛利率 | 50.6% | 30.8% |
| 营业利润率 | -140.7% | 17.5% |
| 净利率 | -145.3% | 11.7% |
| 营收同比 | — | 11.1% |
| 净利润同比 | — | 7.2% |
| 每股收益（稀释后） | $-0.64 | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KMTSPDEX
| Q4 25 | $22.6M | $18.7M | ||
| Q3 25 | $19.4M | $18.5M | ||
| Q2 25 | — | $17.5M | ||
| Q1 25 | — | $17.4M | ||
| Q4 24 | — | $16.8M | ||
| Q3 24 | — | $14.9M | ||
| Q2 24 | — | $15.0M | ||
| Q1 24 | — | $14.3M |
净利润KMTSPDEX
| Q4 25 | $-32.8M | $2.2M | ||
| Q3 25 | $-25.8M | $4.7M | ||
| Q2 25 | — | $1.2M | ||
| Q1 25 | — | $3.3M | ||
| Q4 24 | — | $2.0M | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $1.6M | ||
| Q1 24 | — | $655.0K |
毛利率KMTSPDEX
| Q4 25 | 50.6% | 30.8% | ||
| Q3 25 | 45.7% | 29.0% | ||
| Q2 25 | — | 19.9% | ||
| Q1 25 | — | 33.3% | ||
| Q4 24 | — | 30.2% | ||
| Q3 24 | — | 34.6% | ||
| Q2 24 | — | 27.2% | ||
| Q1 24 | — | 28.0% |
营业利润率KMTSPDEX
| Q4 25 | -140.7% | 17.5% | ||
| Q3 25 | -149.1% | 16.8% | ||
| Q2 25 | — | 7.7% | ||
| Q1 25 | — | 20.9% | ||
| Q4 24 | — | 16.0% | ||
| Q3 24 | — | 20.2% | ||
| Q2 24 | — | 15.6% | ||
| Q1 24 | — | 15.5% |
净利率KMTSPDEX
| Q4 25 | -145.3% | 11.7% | ||
| Q3 25 | -133.3% | 25.3% | ||
| Q2 25 | — | 6.8% | ||
| Q1 25 | — | 18.8% | ||
| Q4 24 | — | 12.1% | ||
| Q3 24 | — | 16.6% | ||
| Q2 24 | — | 10.6% | ||
| Q1 24 | — | 4.6% |
每股收益（稀释后）KMTSPDEX
| Q4 25 | $-0.64 | $0.66 | ||
| Q3 25 | $-0.50 | $1.40 | ||
| Q2 25 | — | $0.33 | ||
| Q1 25 | — | $0.98 | ||
| Q4 24 | — | $0.61 | ||
| Q3 24 | — | $0.75 | ||
| Q2 24 | — | $0.44 | ||
| Q1 24 | — | $0.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $175.4M | $6.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $164.1M | $41.6M |
| 总资产 | $246.7M | $62.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KMTSPDEX
| Q4 25 | $175.4M | $6.1M | ||
| Q3 25 | $201.2M | $10.1M | ||
| Q2 25 | — | $6.8M | ||
| Q1 25 | — | $5.5M | ||
| Q4 24 | — | $4.7M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $6.8M | ||
| Q1 24 | — | $7.8M |
总债务KMTSPDEX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $15.4M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $12.0M | ||
| Q1 24 | — | — |
股东权益KMTSPDEX
| Q4 25 | $164.1M | $41.6M | ||
| Q3 25 | $184.2M | $41.5M | ||
| Q2 25 | — | $36.6M | ||
| Q1 25 | — | $35.3M | ||
| Q4 24 | — | $31.8M | ||
| Q3 24 | — | $30.9M | ||
| Q2 24 | — | $30.9M | ||
| Q1 24 | — | $30.9M |
总资产KMTSPDEX
| Q4 25 | $246.7M | $62.3M | ||
| Q3 25 | $266.3M | $64.3M | ||
| Q2 25 | — | $61.2M | ||
| Q1 25 | — | $64.3M | ||
| Q4 24 | — | $60.4M | ||
| Q3 24 | — | $54.3M | ||
| Q2 24 | — | $52.5M | ||
| Q1 24 | — | $50.5M |
负债/权益比KMTSPDEX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.42× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.39× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-18.3M | $3.6M |
| 自由现金流经营现金流 - 资本支出 | $-25.6M | $3.5M |
| 自由现金流率自由现金流/营收 | -113.5% | 18.8% |
| 资本支出强度资本支出/营收 | 32.2% | 0.4% |
| 现金转化率经营现金流/净利润 | — | 1.63× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流KMTSPDEX
| Q4 25 | $-18.3M | $3.6M | ||
| Q3 25 | $-26.3M | $2.3M | ||
| Q2 25 | — | $-173.0K | ||
| Q1 25 | — | $754.0K | ||
| Q4 24 | — | $-4.2M | ||
| Q3 24 | — | $1.9M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | $4.1M |
自由现金流KMTSPDEX
| Q4 25 | $-25.6M | $3.5M | ||
| Q3 25 | $-34.4M | $2.2M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $574.0K | ||
| Q4 24 | — | $-4.7M | ||
| Q3 24 | — | $1.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $4.0M |
自由现金流率KMTSPDEX
| Q4 25 | -113.5% | 18.8% | ||
| Q3 25 | -177.8% | 11.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | -27.9% | ||
| Q3 24 | — | 9.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 27.7% |
资本支出强度KMTSPDEX
| Q4 25 | 32.2% | 0.4% | ||
| Q3 25 | 42.2% | 0.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 3.2% | ||
| Q3 24 | — | 2.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.8% |
现金转化率KMTSPDEX
| Q4 25 | — | 1.63× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | -0.14× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | -2.03× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 6.22× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
